Search details
1.
Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.
Cell
; 155(4): 844-57, 2013 Nov 07.
Article
in English
| MEDLINE | ID: mdl-24209622
2.
Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.
Gut
; 73(4): 639-648, 2024 Mar 07.
Article
in English
| MEDLINE | ID: mdl-38123998
3.
Efficacy and Safety of Radiation Segmentectomy with 90Y Resin Microspheres for Hepatocellular Carcinoma.
Radiology
; 311(2): e231386, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38713023
4.
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.
Gastroenterology
; 160(4): 1373-1383.e6, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33333055
5.
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma.
Invest New Drugs
; 40(1): 81-90, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34417914
6.
Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
Dig Dis Sci
; 67(7): 3455-3463, 2022 07.
Article
in English
| MEDLINE | ID: mdl-34297268
7.
Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres.
Eur Radiol
; 31(3): 1316-1324, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-32901301
8.
Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma.
J Vasc Interv Radiol
; 32(11): 1560-1568, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34454031
9.
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma.
Invest New Drugs
; 38(3): 800-811, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31297636
10.
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Genet Med
; 21(1): 213-223, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29961768
11.
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
JAMA
; 321(14): 1370-1379, 2019 04 09.
Article
in English
| MEDLINE | ID: mdl-30964527
12.
A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.
Oncologist
; 23(6): 658-e72, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29511132
13.
What Patients Look for When Browsing Online for Pancreatic Cancer: The Bait Behind the Byte.
World J Surg
; 42(12): 4097-4106, 2018 12.
Article
in English
| MEDLINE | ID: mdl-29971463
14.
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.
Br J Cancer
; 117(12): 1874-1882, 2017 Dec 05.
Article
in English
| MEDLINE | ID: mdl-28982112
15.
Surgical Management of Gallbladder Cancer: Simple Versus Extended Cholecystectomy and the Role of Adjuvant Therapy.
Ann Surg
; 266(4): 625-631, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28692469
16.
Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.
Dig Dis Sci
; 61(9): 2749-54, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27038447
17.
The effect of priming with a love concept on blood donation promise.
Transfus Apher Sci
; 50(1): 87-91, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24295729
18.
Polo-like Kinase 1 Inhibition in KRAS-Mutated Metastatic Colorectal Cancer.
Clin Cancer Res
; 30(10): 2005-2007, 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38470499
19.
Efficacy of dual checkpoint inhibitors in a patient with a mixed hepatocellular cholangiocarcinoma.
BMJ Case Rep
; 17(5)2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38697678
20.
First-in-human phase I dose escalation trial of the first-in-class tumor microenvironment modulator VT1021 in advanced solid tumors.
Commun Med (Lond)
; 4(1): 10, 2024 Jan 13.
Article
in English
| MEDLINE | ID: mdl-38218979